Innovative Platform ProofPilot offers the industry’s first end-to-end Clinical Experience Platform (CXP), positioning it as a comprehensive solution for sponsors seeking to streamline patient recruitment, retention, and engagement in clinical trials. This opens opportunities to target organizations looking to enhance trial efficiency and patient experience.

Strong Funding & Growth With recent financing of $7.7 million and significant investments in expanding its clinical trial capabilities including the acquisition of Lokavant, ProofPilot demonstrates strong financial backing and growth potential, making it a compelling partner for healthcare organizations and clinical service providers.

Market Presence & Events ProofPilot actively participates in industry events like SCOPE 2025 and launched its own CORE Symposium, which enhances its visibility among clinical operations professionals. This indicates a strategic focus on relationship-building and positioning as a thought leader, offering engagement opportunities for partners and clients.

Strategic Leadership Recent executive hires such as Vice President of Clinical Strategy and SVP of Customer Success reflect a focus on strengthening strategic and customer-centric capabilities. This can translate into tailored solutions for complex client needs, creating upsell and cross-sell opportunities.

Growth in Revenue With revenues estimated between $25 million and $50 million and a relatively lean team, ProofPilot presents an attractive, agile partnership opportunity for companies in the clinical trials space seeking innovative digital solutions to improve operational outcomes.